Patent details

EP3254671 Title: HIGH CONCENTRATION IMMUNOGLOBULIN COMPOSITION FOR PHARMACEUTICAL APPLICATION

Basic Information

Publication number:
EP3254671
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161740196
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIGH CONCENTRATION IMMUNOGLOBULIN COMPOSITION FOR PHARMACEUTICAL APPLICATION
French Title of Invention:
COMPOSITION D'IMMUNOGLOBULINE À CONCENTRATION ÉLEVÉE POUR APPLICATION PHARMACEUTIQUE
German Title of Invention:
HOCHKONZENTRIERTE IMMUNGLOBULINZUSAMMENSETZUNG ZUR PHARMAZEUTISCHEN ANWENDUNG
SPC Number:

Dates

Filing date:
10/06/2016
Grant date:
13/11/2019
EP Publication Date:
13/12/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/11/2019
EP B1 Publication Date:
13/11/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/06/2020
Expiration date:
10/06/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/11/2019
 
 

Name:
Octapharma AG
Address:
Seidenstrasse 2, 8853 Lachen, Switzerland (CH)

Inventor

1

Name:
Kaar, Waltraud
Address:
Austria (AT)

2

Name:
Rössl, Ulrich
Address:
Austria (AT)

3

Name:
Ahrer, Karin
Address:
Austria (AT)

Classification

IPC classification:
A61K 9/00; A61K 9/08; A61K 47/18;

Publication

European Patent Bulletin

Issue number:
201946
Publication date:
13/11/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages